Article
A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes
16 Nov 2016
Abstract excerpt
Abstract Resistance to hormonal therapies is a major clinical problem in the treatment of estrogen receptor α–positive (ERα+) breast cancers. Epigenetic marks, namely DNA methylation of cytosine at specific CpG sites (5mCpG), are frequently associated with ERα+ status in human breast cancers. Therefore, ERα may regulate gene expression in part via DNA methylation. This hypothesis was evaluated using a panel of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
